KBL Healthcare Ventures
KBL is a venture capital firm dedicated to investing in early stage and emerging growth healthcare companies.
Business Model:
Revenue: $0
Employees: 2-10
Rankings
Industries / Tags:
Detailed KBL Healthcare Ventures Information
Geographic Data
Address: 150 West 56th Street
City: New York
State: NY
Zip: 10019
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$100M
Social
Facebook
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
KBL is a venture capital firm dedicated to investing in early stage and emerging growth healthcare companies. Their goal is to identify companies that are run by seasoned management teams and that have the potential to create long term value. They feel that the convergence of biology, chemistry, physics and computer science will spark the creation of several new paradigms within healthcare. Major areas of investment include life sciences, medical devices, healthcare services and medical information technology. Within the life sciences space, they will invest in biopharmaceuticals, drug discovery platforms and advanced materials. Within the medical device area, they seek companies addressing large, unmet medical needs with demonstrated clinical benefit.
Contact Phone:
+12123195555
Contact Email:
KBL Healthcare Ventures went public on 6/23/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/23/2017
IPO Valuation:
$130M
Ticker Symbol:
KBLMU
IPO Price:
$10/share
Amount Raised:
$115M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2005 | PneumRx | Series A | 0 |
| 1/2002 | Achillion Pharmaceuticals | Venture Round | 41M |
| 7/2003 | Lumenos | Venture Round | 10M |
| 1/2000 | EpiCept Corporation | Series B | 4.6M |
| 9/2004 | Remon Medical Technologies | Series C | 16M |
| 2/2005 | Scandius BioMedical | Series C | 0 |
| 10/2009 | Neuronetics | Series D | 0 |
| 2/2011 | CardioFocus | Series C | 0 |
| 5/2014 | CardioFocus | Debt Financing | 0 |
| 8/2006 | Neuronetics | Series C | 0 |
| 3/2007 | PneumRx | Series B | 0 |
| 7/2000 | Lumenos | Series B | 34M |
| 8/2001 | Spinal Concepts | Series E | 21M |
| 11/2006 | Magellan Diagnostics | Private Equity Round | 0 |
| 1/2004 | Scandius BioMedical | Series B | 0 |
| 4/2003 | Neuronetics | Series A | 15M |
| 1/2005 | Remon Medical Technologies | Series C | 0 |
| 6/2017 | Neuronetics | Series G | 0 |
| 6/2017 | Neuronetics | Series G | 0 |
| 5/2014 | CardioFocus | Debt Financing | 0 |
| 2/2011 | CardioFocus | Series C | 0 |
| 10/2009 | Neuronetics | Series D | 0 |
| 3/2007 | PneumRx | Series B | 0 |
| 11/2006 | Magellan Diagnostics | Private Equity Round | 0 |
| 8/2006 | Neuronetics | Series C | 0 |
| 6/2005 | PneumRx | Series A | 0 |
| 2/2005 | Scandius BioMedical | Series C | 0 |
| 1/2005 | Remon Medical Technologies | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
